Ukoha Erinma P, Wen Timothy, Reddy Uma M
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, CA.
Am J Obstet Gynecol. 2025 Mar;232(3):321.e1-321.e10. doi: 10.1016/j.ajog.2024.06.001. Epub 2024 Jun 7.
Studies that have compared induction of labor in individuals with 1 prior cesarean delivery to expectant management have shown conflicting results.
To determine the association between clinical outcomes and induction of labor at 39 weeks in a national sample of otherwise low-risk patients with 1 prior cesarean delivery.
This cross-sectional study analyzed 2016 to 2021 US Vital Statistics birth certificate data. Individuals with vertex, singleton pregnancies, and 1 prior cesarean delivery were included. Patients with prior vaginal deliveries, delivery before 39 weeks 0 days or after 42 weeks 6 days of gestation, and medical comorbidities were excluded. The primary exposure of interest was induction of labor at 39 weeks 0 days to 39 weeks 6 days compared to expectant management with delivery from 40 weeks 0 days to 42 weeks 6 days. The primary outcome was vaginal delivery. The main secondary outcomes were separate maternal and neonatal morbidity composites. The maternal morbidity composite included uterine rupture, operative vaginal delivery, peripartum hysterectomy, intensive care unit admission, and transfusion. The neonatal morbidity composite included neonatal intensive care unit admission, Apgar score less than 5 at 5 minutes, immediate ventilation, prolonged ventilation, and seizure or serious neurological dysfunction. Unadjusted and adjusted log binomial regression models accounting for demographic variables and the exposure of interest (induction vs expectant management) were performed. Results are presented as unadjusted and adjusted risk ratios with 95% confidence intervals.
From 2016 to 2021, a total of 198,797 individuals with vertex, singleton pregnancies, and 1 prior cesarean were included in the primary analysis. Of these individuals, 25,915 (13.0%) underwent induction of labor from 39 weeks 0 days to 39 weeks 6 days and 172,882 (87.0%) were expectantly managed with deliveries between 40 weeks 0 days and 42 weeks 6 days. In adjusted analyses, patients induced at 39 weeks were more likely to have a vaginal delivery when compared to those expectantly managed (38.0% vs 31.8%; adjusted risk ratio 1.32, 95% confidence interval 1.28, 1.36). Among those who had vaginal deliveries, induction of labor was associated with increased likelihood of operative vaginal delivery (11.1% vs 10.0; adjusted risk ratio 1.15, 95% confidence interval 1.07, 1.24). The maternal morbidity composite occurred in 0.9% of individuals in both the induction and expectant management groups (adjusted risk ratio 0.92, 95% confidence interval 0.79, 1.06). The rates of uterine rupture (0.3%), peripartum hysterectomy (0.04% vs 0.05%), and intensive care unit admission (0.1% vs 0.2%) were all relatively low and did not differ significantly between groups. There was also no significant difference in the neonatal morbidity composite between the induction and expectant management groups (7.3% vs 6.7%; adjusted risk ratio 1.04, 95% confidence interval 0.98, 1.09).
When compared to expectant management, elective induction of labor at 39 weeks in low-risk patients with 1 prior cesarean delivery was associated with a significantly higher likelihood of vaginal delivery with no difference in composite maternal and neonatal morbidity outcomes. Prospective studies are needed to better elucidate the risks and benefits of induction of labor in this patient population.
将有过一次剖宫产史的孕妇引产与期待治疗进行比较的研究结果相互矛盾。
在全国范围内抽取的有过一次剖宫产史、其他方面为低风险的患者样本中,确定39周引产与临床结局之间的关联。
这项横断面研究分析了2016年至2021年美国生命统计出生证明数据。纳入单胎头位妊娠且有过一次剖宫产史的孕妇。排除有过阴道分娩史、妊娠39周0天前或42周6天后分娩以及有合并症的患者。主要关注的暴露因素是妊娠39周0天至39周6天引产与40周0天至42周6天期待治疗并分娩相比。主要结局是阴道分娩。主要次要结局是分别的孕产妇和新生儿发病综合指标。孕产妇发病综合指标包括子宫破裂、阴道助产、产后子宫切除术、入住重症监护病房和输血。新生儿发病综合指标包括新生儿入住重症监护病房、5分钟时阿氏评分低于5分、即刻通气、延长通气以及惊厥或严重神经功能障碍。进行了未调整和调整后的对数二项回归模型分析,纳入了人口统计学变量和感兴趣的暴露因素(引产与期待治疗)。结果以未调整和调整后的风险比及95%置信区间呈现。
2016年至2021年,共有198,797名单胎头位妊娠且有过一次剖宫产史的孕妇纳入主要分析。其中,25,915名(13.0%)在妊娠39周0天至39周6天接受引产,172,882名(87.0%)接受40周0天至42周6天的期待治疗并分娩。在调整分析中,与接受期待治疗的患者相比,39周引产的患者阴道分娩的可能性更高(38.0%对31.8%;调整后风险比1.32,95%置信区间1.28,1.36)。在阴道分娩的患者中,引产与阴道助产可能性增加相关(11.1%对10.0%;调整后风险比1.15,9%置信区间1.07,1.24)。引产组和期待治疗组中孕产妇发病综合指标的发生率均为0.9%(调整后风险比0.92,95%置信区间0.79,1.06)。子宫破裂率(0.3%)、产后子宫切除率(0.04%对0.05%)和入住重症监护病房率(0.1%对0.2%)均相对较低,两组间无显著差异。引产组和期待治疗组新生儿发病综合指标也无显著差异(7.3%对6.7%;调整后风险比1.04,95%置信区间0.98,1.09)。
与期待治疗相比,有过一次剖宫产史的低风险患者在39周择期引产与阴道分娩可能性显著更高相关,且孕产妇和新生儿发病综合结局无差异。需要进行前瞻性研究以更好地阐明该患者群体引产的风险和益处。